(Q42803401)

7 November 2017

title

Detection of soluble human granzyme K in vitro and in vivo (English)

1 reference

7 November 2017

0 references

Britta Bade

1

1 reference

7 November 2017

Jens Lohrmann

2

1 reference

7 November 2017

Anja ten Brinke

3

1 reference

7 November 2017

Angela M Wolbink

4

1 reference

7 November 2017

Gert-Jan Wolbink

5

1 reference

7 November 2017

Ineke J M ten Berge

6

1 reference

7 November 2017

J Christian Virchow

7

1 reference

7 November 2017

Werner Luttmann

8

1 reference

7 November 2017

C Erik Hack

9

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

European Journal of Immunology

7 November 2017

published in

1 reference

7 November 2017

volume

35

1 reference

7 November 2017

issue

10

1 reference

7 November 2017

page(s)

2940-2948

1 reference

describes a project that uses

7 November 2017

GM26E7

0 references

GM6C3

0 references

cites work

The restricted expression of granzyme M in human lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Granzyme A is an interleukin 1 beta-converting enzyme

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Extracellular Activities of Human Granzymes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Cell death induced by granzyme C.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Granzyme M mediates a novel form of perforin-dependent cell death

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

The genes encoding NK cell granule serine proteases, human tryptase-2 (TRYP2) and human granzyme A (HFSP), both map to chromosome 5q11-q12 and define a new locus for cytotoxic lymphocyte granule tryptases.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Bioinformatics of granzymes: sequence comparison and structural studies on granzyme family by homology modeling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Mitochondria-dependent and -independent regulation of Granzyme B-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Rapid purification of cationic granule proteases: application to human granzymes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Discordant regulation of granzyme H and granzyme B expression in human lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Expression of granzyme B during primary cytomegalovirus infection after renal transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526249

7 January 2021

Identifiers

DOI

10.1002/EJI.200526249

1 reference

7 November 2017

1 reference